- Aleafia Health (AH) has secured a Health Canada Research Licence for human sensory analysis trials of cannabis products
- The company will conduct the research at its cannabis product manufacturing and innovation centre in Paris, Ontario
- The company intends to allow human panels to evaluate objective product characteristics, and evaluate preference between comparable products
- Aleafia is currently developing a number of new product formats and line extensions to complement its existing portfolio
- Aleafia Health is unchanged on the day, with shares of the company trading at C$0.52 at 1:17 pm ET
Aleafia Health (AH) has secured a Health Canada Research Licence for human sensory analysis trials of cannabis products.
The global cannabis wellness products and services company will conduct the research at its cannabis product manufacturing and innovation centre in Paris, Ontario.
The licence allows the company to conduct human sensory analysis and palatability trials, evaluating the taste, touch, smell and sight of its growing portfolio of differentiated medical and consumer cannabis products.
Aleafia Health is currently developing a number of new product formats and line extensions to complement its existing cannabis portfolio of dried flower, edibles, sublingual strips, soft gels, extracts, and vape cartridges. The company intends to conduct sensory assessment studies consistently during product development, allowing human panels to evaluate objective product characteristics, and evaluate preference between comparable products.
“As we continue to bring highly innovative formats to market, our development team will now employ an important best practice of product evaluation used in the food and beverage industries. Through a first to market product strategy, we’ve developed a track record for product innovation that will only be strengthened by this regulatory breakthrough,” said Aleafia Health CEO Geoffrey Benic.
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany.
The company operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health is unchanged on the day, with shares of the company trading at C$0.52 at 1:17 pm ET.
